Cargando…
SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity
Autores principales: | Anft, Moritz, Paniskaki, Krystallenia, Giglio, Tina, Wellenkötter, Jacqueline, Blazquez-Navarro, Arturo, Meister, Toni L., Roch, Toralf, Giesecke-Thiel, Claudia, Westhoff, Timm H., Stervbo, Ulrik, Pfaender, Stephanie, Cinkilic, Okan, Babel, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624106/ https://www.ncbi.nlm.nih.gov/pubmed/36332726 http://dx.doi.org/10.1016/j.kint.2022.10.012 |
Ejemplares similares
-
A Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19 Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity in Renal Transplant Recipients
por: Roch, Toralf, et al.
Publicado: (2022) -
Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses
por: Cinkilic, Okan, et al.
Publicado: (2022) -
Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease
por: Stervbo, Ulrik, et al.
Publicado: (2021) -
Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients
por: Blazquez-Navarro, Arturo, et al.
Publicado: (2021) -
Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
por: Anft, Moritz, et al.
Publicado: (2022)